Lessons from catheter ablation: how a proarrhythmic effect has become a therapeutic chance. The case of class IC/III drugs in atrial flutter.
Catanzariti
Domenico
D
Vergara
Giuseppe
G
D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000145:classification / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy / Q000517:prevention & control*; D001282:Atrial Flutter / Q000139:chemically induced / Q000517:prevention & control* / Q000628:therapy; D017115:Catheter Ablation; D006801:Humans
D000889:Anti-Arrhythmia Agents